In this work, a complex in vivo model of tumors accompanied by surgical wound infection was applied. Bacteriophages modified with anticancer YIGSR peptides acted as the active agents. Evaluation ...

New insights into a "friendly virus" that could pave the way for cutting-edge treatments for the potentially fatal superbug C ...

This important study analyzes the effect of heat treatment on phage-bacterial interactions and convincingly shows that prior heat exposure alters the bacterial cell envelope, enhancing persistence and ...

BX211 was safe and well-toleratedBX211 produced sustained and statistically significant1 Percent Area Reduction (PAR) of ulcer size (p = 0.046 at ...

Clostridioides difficile infection is a major healthcare-associated infection, causing significant morbidity and mortality, ...

Known as phage therapy, it uses viruses to kill harmful bacteria in difficult-to-treat infections. Read more at ...

Armata is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat ...

Returning to Boston this February, the Bacteriophage Therapy Summit is the only global platform for industry-dominated phage drug developers. Uniting 90+ Chief Executive Officers, Vice Presidents ...